ofloxacin has been researched along with Phlebitis in 4 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Phlebitis: Inflammation of a vein, often a vein in the leg. Phlebitis associated with a blood clot is called (THROMBOPHLEBITIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Infusion phlebitis is a common clinical problem that is observed with some antimicrobial agents, when being administered intravenously." | 1.34 | Effect of quinupristin/dalfopristin on 3T3 and Eahy926 cells in vitro in comparison to other antimicrobial agents with the potential to induce infusion phlebitis. ( Flick, B; Kilic, B; Kruse, M; Stahlmann, R, 2007) |
| "Infusion phlebitis is a common clinical problem associated with some antimicrobial agents." | 1.33 | The in vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926). ( Kilic, B; Kruse, M; Stahlmann, R, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fusco, S | 1 |
| Reitano, F | 1 |
| Gambadoro, N | 1 |
| Previti, M | 1 |
| Russo, G | 1 |
| Basile, G | 1 |
| Cucinotta, D | 1 |
| Kilic, B | 2 |
| Kruse, M | 2 |
| Stahlmann, R | 2 |
| Flick, B | 1 |
| Karachalios, GN | 1 |
| Nasiopoulou, DD | 1 |
| Bourlinou, PK | 1 |
| Reppa, A | 1 |
1 trial available for ofloxacin and Phlebitis
| Article | Year |
|---|---|
Treatment of acute biliary tract infections with ofloxacin: a randomized, controlled clinical trial.
Topics: Anti-Infective Agents; Bacteremia; Ceftriaxone; Cephalosporins; Cholangitis; Cholecystitis; Escheric | 1996 |
3 other studies available for ofloxacin and Phlebitis
| Article | Year |
|---|---|
Severe hypoglycemia associated with levofloxacin in a healthy older woman.
Topics: Administration, Oral; Aged, 80 and over; Anti-Bacterial Agents; Blood Glucose; Female; Humans; Hypog | 2013 |
The in vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926).
Topics: Anti-Bacterial Agents; Cell Adhesion Molecules; Cell Line; Dose-Response Relationship, Drug; Endothe | 2006 |
Effect of quinupristin/dalfopristin on 3T3 and Eahy926 cells in vitro in comparison to other antimicrobial agents with the potential to induce infusion phlebitis.
Topics: Animals; Anti-Bacterial Agents; BALB 3T3 Cells; Cell Survival; Dose-Response Relationship, Drug; End | 2007 |